At recent prices, $100 is enough to buy shares of both Royalty Pharma and AT&T. AT&T offers a high dividend yield, and it ...

COSCIENS Biopharma Inc. ("COSCIENS" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical ...

Earlier this year, the company entered into a $575 million funding collaboration with Royalty Pharma. The partnership ...

ForecastHeidelberg Pharma AG Announces Updated Guidance01-Oct-2024 / 15:27 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS ...

Over the next three months, the agency could approve a rival to a fast-selling Pfizer heart drug, a much-debated lung cancer medicine and an addition to Vertex's dominant cystic fibrosis business.

Approximately 50,000 ILA union longshoremen were walking off the job at East Coast and Gulf Coast ports from New England to ...

Mankind Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Royalty Income for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, the company has ...

The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use one or multiple different selling models. However, how many pharma executives ...

Israeli troops crossed the border for the first time since 2006 in a ground operation targeting Hezbollah. The Israeli military called for evacuations in southern Lebanon. As a Crisis Builds ...

'Trust has become biggest casualty': What Army chief said on LAC standoff with China Army Chief Upendra Dwivedi stated that the situation along the LAC in eastern Ladakh is stable but sensitive ...

A trader works on the trading floor at The New York Stock Exchange (NYSE), in New York City, U.S., September 18, 2024. REUTERS/Andrew Kelly/File Photo The S&P 500 sputtered to a record high close ...

U.S. Marketscategory New York Fed's reverse repo facility sees cash surge on last day of Q3 September 30, 2024 U.S. Marketscategory Exclusive: Fed's Bostic open to another large rate cut if job ...